The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.
S-Biomedic changes the paradigm in dermatology and skin care. We developed a breakthrough skin microbiome modulation technology that changes lives of millions of people who suffer from acne, skin age damage, psoriasis, or squamous cell carcinoma.
Beerse, Région flamande, Belgium
Send a message
The CEO of S-Biomedic joins selected biotech leaders such as George Church, J. Craig Venter or Bill Gates to share their thoughts on the future of the sector.
Veronika Oudova: The future for many new biotech companies will increasingly be driven by the lean business concept. Biotech is crucial to ignite the paradigm shifts that our world requires, but we must not forget that great science alone doesn’t make a successful company. I believe that we will see more alternative and innovative business models in the industry in the same way we already do in the microbiome sector and that we will leverage learnings from other tech sectors to increase our success rates and to accelerate our reach to consumers.
Read more at: https://www.nature.com/articles/s41587-021-00941-4
Start in 2014
S-Biomedic founders get together and put their idea of the skin microbiome modulation on a paper
StartUp Chile Acceleration program - first business plan and initial in vitro data
2015 - 2016
S-Biomedic joins the Dermatology unit at University Clinic Magdeburg to generate first clinical data
The team joins JLABS - incubation labs of Johnson & Johnson Innovation and company is incorporated
Series A round welcoming JJDC, Beiersdorf, DSM and Verve Partners on board as investors
to be continued ...